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Physiologic Pacing in Patients
ith Obstructive Sleep Apnea
Prospective, Randomized Crossover Trial
ndrew D. Krahn, MD,* Raymond Yee, MD,* Mark K. Erickson, BSC,† Toby Markowitz, BSEE,†
orne J. Gula, MD,* George J. Klein, MD,* Allan C. Skanes, MD,* Charles F. P. George, MD,*
athleen A. Ferguson, MD*
ondon, Canada; and Minneapolis, Minnesota
OBJECTIVES This study was designed to assess the impact of prevention of bradycardia with physiologic
pacing on the severity of obstructive sleep apnea.
BACKGROUND Apneic episodes during sleep are associated with slowing of the heart rate during apnea and
tachycardia with subsequent arousal. Patients with permanent pacemakers may have reduced
episodes of sleep apnea when their pacemaker rate is set faster than their spontaneous
nocturnal heart rate.
METHODS We conducted a prospective, randomized, single-blind crossover trial of temporary atrial
pacing in obstructive sleep apnea to reduce the apnea hypopnea index (AHI). Fifteen patients
(age 60  13 years, 12 men) with moderate to severe obstructive sleep apnea (AHI 34  14)
underwent insertion of an externalized atrial permanent pacing system via the left subclavian
vein. Patients underwent overnight respiratory sleep studies in hospital, during atrial pacing
at 75 beats/min, and with pacing turned off. The order of pacing mode was randomized, with
crossover the subsequent night to the other mode. Patients were blinded to pacing mode, and
the analysis of sleep recordings was blind to pacing mode.
RESULTS Pacing was tolerated without complications in all patients. Overnight physiologic pacing did
not affect the AHI (pacing 39  21/h vs. control 42  21/h, p  0.23, 95% confidence
interval 9.3 to 2.5 for difference), desaturation time (pacing 3.8  6.0% vs. control 3.5 
4.3%, p  0.70), or the minimum SaO2 (pacing 75  10% vs. control 77  11%, p  0.38).
There was a borderline significant reduction in circulatory time with pacing (pacing 23.4 
3.2 s vs. control 25.5  4.4 s, p  0.09).
CONCLUSIONS Temporary atrial pacing does not appear to improve respiratory manifestations of obstructive
sleep apnea. Permanent atrial pacing in this patient population does not appear to be
justified. (J Am Coll Cardiol 2006;47:379–83) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.026Cardiology Foundation
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nleep apnea syndrome is a disorder characterized by recur-
ent episodes of apnea during sleep, typically producing
xcessive daytime sleepiness (1). The disorder is associated
ith significant morbidity and mortality and is significantly
nderdiagnosed and undertreated (2–4). Sleep apnea is
iagnosed when the apnea-hypopnea index (AHI) is at least
and symptoms are present. Based upon these criteria, 4%
f middle-age men and 2% of middle-age women are
ffected (1).
Apneic episodes during sleep are generally associated
ith profound bradycardia with cyclical variation of the
eart rate during apnea and resumption of breathing (5).
arrigue et al. (6) reported that nocturnal atrial overdrive
acing resulted in an improvement in the frequency of sleep
pnea events in patients. Fifteen subjects with dual-chamber
From the *Divisions of Cardiology and Respirology, University of Western
ntario, London, Canada; and †Medtronic Inc., Minneapolis, Minnesota. This study
as funded by Medtronic Inc., Minneapolis, Minnesota. Drs. Krahn, Yee, and Klein
ave received consulting fees from Medtronic and have been paid speakers for
edtronic Inc. Mr. Erickson and Mr. Markowitz are employees of Medtronic Inc.
r. George has received consulting fees and is on the medical advisory board for
leepTech LLC (Kinnelon, New Jersey). Dr. Ferguson has received grant support and
as been a paid speaker for Respironics Inc.f
Manuscript received May 13, 2005; revised manuscript received August 4, 2005,
ccepted September 8, 2005.acemakers and mild to moderate sleep apnea were ran-
omized, in a crossover design, to DDD pacing at 15
eats/min above the spontaneous nocturnal heart rate or
pontaneous rhythm with VVI backup pacing at 40 beats/
in. Overnight polysomnography demonstrated a 60%
eduction in AHI. Nocturnal atrial overdrive pacing reduced
oth central and obstructive apnea and hypopnea. Impor-
antly, the patients were derived from a population of
acemaker patients with symptoms suggesting sleep apnea,
ith subsequent testing suggesting a mixed population of
bstructive sleep apnea (OSA) and central sleep apnea.
Patients with pacemakers represent a small percentage of
eople with sleep apnea. Our goal was to examine the effect
f temporary nocturnal atrial overdrive pacing in subjects
ith a primary diagnosis of obstructive sleep apnea syn-
rome who did not have a conventional indication for
acing. We hypothesized that an increase in physiologic
eart rate would reduce the number and severity of apneic
vents. If temporary pacing reduced apnea severity, perma-
ent atrial pacing might represent a potential treatment
ption for patients with OSA, particularly patients in whom
asal continuous positive airway pressure (CPAP) had
ailed.
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tudy population. Subjects with previously diagnosed
leep apnea without standard indications for cardiac pacing
ere recruited to undergo two consecutive night sleep
tudies with temporary pacing randomized to no pacing or
AI at a lower rate of 75 beats/min. Subjects were recruited
rom a local sleep clinic with new or previously diagnosed
SA. Patients had moderate to severe sleep apnea (AHI 10
o 50) on overnight polysomnography. The baseline diag-
ostic sleep study montage included electroencephalogram
C3/A2, C4/A1, O2/A1), electrooculogram, submental
lectromyogram (EMG), left and right anterior tibialis
MG, electrocardiogram (ECG), thoraco-abdominal mo-
ion, oronasal airflow (nasal pressure), and arterial oxygen
aturation with pulse oximetry. The studies were scored
anually, and the total AHI was calculated for the night.
bstructive apneas were defined as the cessation of airflow
or at least 10 s accompanied by ongoing respiratory effort.
bstructive hypopnea was defined as a reduction in airflow
f at least 50% for at least 10 s accompanied by a reduction
n respiratory effort and by an arousal or an arterial oxygen
esaturation of at least 3%.
Subjects had refused or failed CPAP, defined as discon-
inuation because of inefficacy and/or intolerance and/or
efusal to continue to use CPAP. Subjects were excluded
rom the study if they were 18 years of age, had a
iagnosis of another sleep disorder in addition to sleep
pnea (including central sleep apnea), were taking sedative
r hypnotic medications, were taking warfarin, had New
ork Heart Association functional class IV heart failure,
ad a previous myocardial infarction or cardiac bypass
urgery, had features suggesting cor pulmonale (hematocrit
50%, awake arterial PCO2 50 mm Hg or severe hypox-
mia during an overnight polysomnogram, SaO2 70%),
ere pregnant, or were unable or unwilling to attend
ollow-up or provide informed consent. Patients that had
evere excessive daytime sleepiness (Epworth Sleepiness
cale [ESS] 15) were excluded because we did not want
ntreated patients with severe sleepiness to be delayed in
etting known effective therapy (CPAP) or stopping CPAP
or an unproven therapy. Patients with a body mass index
40 kg/m2 were excluded because they tend to have severe
SA that is most effectively treated with CPAP, and the
rotocol mandated that they be untreated for at least two
Abbreviations and Acronyms
AHI  apnea hypopnea index
CPAP  continuous positive airway pressure
ECG  electrocardiogram
EMG  electromyogram
ESS  Epworth Sleepiness Scale
OSA  obstructive sleep apnea
SaO2  oxygen saturationeeks before testing (to wash out any effect of CPAP). The aotential risks and benefits of atrial pacing and central
enous cannulation were explained in detail. All subjects
rovided written informed consent. The Health Sciences
esearch Ethics Board of the University of Western On-
ario approved the protocol.
acing and sleep study. The study was a single-blind
andomized crossover design with a control and treatment
rm. Subjects presented for insertion of a temporary pacing
ystem after fasting for a minimum of 6 h. Using sterile
echnique and local anesthetic, subjects underwent cannu-
ation of the left subclavian vein. An active fixation, bipolar,
ermanent pacing lead (Model 5076, Medtronic Inc., Min-
eapolis, Minnesota) was introduced though a 5-mm cuta-
eous incision and advanced to the right atrial appendage
nder fluoroscopic guidance. After adequate pacing and
ensing thresholds were verified, the pacing lead was con-
ected to an external permanent pacing generator (Model
SR 903, Medtronic Inc.) and fixed to the skin with a
uture to anchor the lead, and a temporary adhesive dressing
as applied over the generator and lead. Output amplitude
as set to 0.4 ms and 3.5 V or two times threshold,
hichever was higher. A chest X-ray was performed to
erify lead position and exclude pneumothorax.
Subjects received AAI pacing at 75 beats/min or OAO
acing (no pacing) on two consecutive nights in a random-
zed, crossover single-blind fashion. The pacemaker was
onnected to the subject for both nights. Overnight respi-
atory recording was performed using the Stardust Respira-
ory Disorder Diagnostic Device (Stardust, Respironics
nc., Murrysville, Pennsylvania). The standard recordings
ncluded measures of oral/nasal airflow (nasal pressure),
espiratory effort, arterial oxygen saturation, heart rate, and
ody position. The parameters from these recordings pro-
ided an assessment of sleep-disordered breathing severity.
DR190 digital Holter monitor (NorthEast Monitoring,
aynard, Massachusetts) capable of recording ECG and
ontinuous pacemaker telemetry was worn both nights.
Following the first night of sleep, the study coordinator
ownloaded recorded data from the pacemaker, the Holter
onitor, and the Stardust recorder; reset the recording
evices; verified normal pacing function; and programmed
he pacemaker to the crossover mode. The following morn-
ng, similar data were retrieved from the devices, and the
ead was removed under fluoroscopic guidance and an
dhesive bandage as applied to the insertion site.
ata collection and analysis. Baseline measurements in-
luded age, gender, weight, body mass index (kg/m2), neck
ircumference, and blood pressure. A research coordinator
dministered the ESS; the Sleep Apnea Subscale of the
leep Disorders Questionnaire; and a detailed questionnaire
bout snoring, sleepiness, and associated features of SAS
Table 1). The primary outcome of the study was the
ifference in AHI during AAI pacing compared with
ontrol patients. We estimated that 13 patients were re-
uired in a crossover design to provide 80% power to detect
50% reduction in AHI. Secondary outcomes included a
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January 17, 2006:379–83 Pacing Does Not Prevent Obstructive Sleep Apneaomparison of treatment and control nights for total study
ime, mean oxygen saturation (SaO2), lowest SaO2, percent
f sleep time with SaO2 90%, mean apnea-hypopnea
uration (s), and circulatory time (time from end of apnea to
adir of SaO2). The studies were scored using the auto-
ated analysis protocol of the Stardust software. An expe-
ienced scorer who was blinded to the treatment status of
he subject then reviewed the studies manually on an
poch-by-epoch basis. Responders to AAI pacing were
efined as subjects who improved by at least one American
cademy of Sleep Medicine classification; severe to mod-
rate, moderate to mild, or mild to normal (7). Continuous
ariables are presented as mean  SD. Continuous data
ere compared using a paired Student t test. A p value at
he 0.05 level or lower was considered significant. Data are
resented as mean  SD.
ESULTS
he 15 subjects enrolled in the trial were predominantly
verweight middle-aged men with borderline hypertension
Table 1). Their average AHI level from diagnostic polysom-
ography was classified as severe at 34  14/h. Twelve of the
5 subjects had used CPAP in the past. Nine of the 15
ubjects were identified as high risk for sleep apnea by the
leep Apnea Subscale of the Sleep Disorders Questionnaire
established cutoffs 32 for women and 36 for men), but
nly 5 of 15 were categorized as sleepy using the ESS
10).
The AHI values during control and AAI pacing for
ndividual subjects are illustrated in Figure 1. Mean AHI
howed no evidence of benefit from pacing (38.6  20.5/h
ontrol vs. 42.1  20.7/h pacing, p  0.23). By American
cademy of Sleep Medicine criteria (7), only one subject
as classified as a responder (Subject #10, AHI reduced
able 1. Patient Characteristics
ge (yrs) 60  13
ender (M/F) 12/3
eight (kg) 95  19
ody mass index (kg/m2)
Median (min–max) 29.9 (21.7–42.0)
Interquartile range 29.4–31.3
eck circumference (cm) 42  4
eck circ 40 cm (n) 11
ystolic BP (mm Hg) 142  14
iastolic BP (mm Hg) 85  13
ongestive heart failure 0
esting ECG normal (%) 14 (93)
nore (yes/no/unknown) 9/2/4
linical AHI 34  14
ast CPAP use (n) 12
SS 7.7  3.8
DQ-SA 38.4  6.9
HI  apnea hypopnea index; BP  blood pressure; CPAP  continuous positive
irway pressure; ECG  electrocardiogram; ESS  Epworth Sleepiness Scale
normal range 0 to 10, higher values imply greater sleepiness); SDQ-SA  Sleep
pnea Subscale of the Sleep Disorders Questionnaire (normal 36 for men, 32 for
omen, higher values imply greater likelihood of sleep apnea).rom 34 to 18).
F
cThe pacing intervention successfully eliminated nocturnal
radycardia with the expected rise in mean heart rate (Fig.
). All subjects increased heart rate with AAI pacing.
ubject #6 had extensive noise on the Holter ECG and the
tardust pulse rate, making reliable heart rate calculations
mpossible. By design, mean heart rate increased from 65 
beats/min during the control night to 77  1 beats/min
uring AAI pacing (p  0.0001). There were no compli-
ations from the lead implant or pacing. Two subjects
omplained of minor tenderness at the lead insertion site.
There was no difference in other indices of sleep apnea
urden, including oxygen saturation, duration of desatura-
ion, and apnea-hypopnea duration (Table 2). There was a
rend toward a reduction in circulatory time during AAI
acing (25.5  4.4 s control vs. 23.4  3.2 s AAI, p 
.09), likely reflecting increased cardiac output attributable
o increased heart rate with AAI pacing.
ISCUSSION
he current study does not support a role for cardiac pacing
n the treatment of obstructive sleep apnea. The apparent
enefit from permanent pacing in patients with both forms
f sleep apnea previously reported was not replicated in
atients that did not require pacing for a conventional
radycardia indication (6). Garrigue et al. (6) focused on
atients with established bradycardia who had a stable
ermanent pacemaker with ongoing findings suggesting
leep apnea during nominal pacing programming. They
ound a benefit from permanent pacing in subjects with
oth central and obstructive apnea that we could not
onfirm in subjects who did not require pacing for a
onventional bradycardia indication. Our population was
omewhat older than is typical for a sleep apnea population,igure 1. Change in apnea hypopnea index (AHI), heart rate (HR), and
irculatory time with overnight atrial pacing.
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Pacing Does Not Prevent Obstructive Sleep Apnea January 17, 2006:379–83ut was similar in age to the Garrigue et al. study (6). We
ought to investigate a role for permanent pacing by testing
linded physiologic pacing in patients who would be ideal
andidates for an alternate approach to improving their
leep apnea but who did not have an indication for pacing.
wo other studies have focused on patients with permanent
acemakers (8,9). Luthje et al. (8) and Pepin et al. (9)
tudied 20 and 15 patients with previously implanted
evices and did not detect any change in the AHI with
octurnal pacing.
Our study demonstrated no effect in this clinically rele-
ant population, suggesting that a large enough clinical
ffect on AHI that would be needed to justify an invasive
trategy using permanent pacing is unlikely to have been
issed. The 95% confidence limits of the effect on AHI
9.3 to 2.5) do not include a sufficient effect to justify an
nvasive strategy that would fail to normalize or markedly
mprove the patient’s sleep apnea. Although a reduction in
HI as much as 9 points appears to represent potential
linical benefit, the risk of hypertension and coronary artery
isease associated with sleep apnea is increased above an
HI of 5 (10–13). In a single small study that found a
eduction in cardiovascular risk in patients treated with
PAP for sleep apnea, the mean AHI fell from 33.7 
6.8/h at baseline to 3.9  2.9/h (10). This target is well
elow the residual AHI burden of disease of 25 that
epresents the optimal estimate of effect from pacing in the
urrent study, suggesting ongoing moderate to severe sleep
pnea. Additional parameters that gauge severity of sleep
isruption, physiologic response to apnea, and patient
ymptoms did not suggest any evidence of benefit. One
ostulate for the previous beneficial observation is that the
tility of pacing may be restricted to improving central sleep
pnea. The concept that atrial pacing would improve ob-
tructive sleep apnea is a speculative one. The Garrigue et al.
6) study showed a greater reduction in apnea index in
entral sleep apnea patients (13  17 to 6  7, p  0.007)
hen compared with obstructive apnea patients (6  4 to 3
1, p  0.03). The central patients had more apnea events
nd had a more dramatic response (14). The improvement
n central sleep apnea with pacing is more consistent with
ur understanding of the physiology of central apnea in
eart failure. The reversal of bradycardia in the autonomic
nd neurohormonal milieu of heart failure seems more likely
Table 2. Results of Atrial Pacing on Select Ind
Parameter Control
Apnea hypopnea index 42.1  20.7
Heart rate (beats/min) 65  7
Time in bed (min) 437  45
Minimum SaO2 (%) 77  11
% time SaO2 90% 3.5  4.3
Apnea hypopnea duration (s) 28.4  4.7
Circulatory time (s) 25.5  4.4
CI  confidence interval; SaO2  oxygen saturation.o have an impact on central sleep apnea and cardiac aunction than does reversal of the secondary bradycardia-
educing OSA (15).
tudy limitations. The current findings are limited to the
mall population studied. Further investigations to explore
he role of pacing in central sleep apnea seem warranted on
he basis of the current study and previous work. Because
atients had failed or refused CPAP, failure of standard
herapy with CPAP may have made it more likely for other
reatments to fail. However, the patients were blinded to the
acing component of the study. One strength of the study
as the crossover design, which minimized the possibility of
period effect by maintaining stable sleeping conditions as
est as feasible under the circumstances. The same design
id not allow for a washout period between nights. There is
o evidence that overnight backup pacing should have led to
ersistent effects; this view is supported by the nonsignifi-
ant test for interaction between the first and second night
Wilcoxon rank-sum test, p  0.10). Given the unproven
nd invasive nature of atrial pacing as a treatment, we felt it
ould not be appropriate to recruit patients with moderate
o severe OSA who had not previously been offered or
reated with CPAP. A full sleep study may have been more
ensitive to detect subtle benefits with more comprehensive
leep data, though the overall primary end point was clearly
egative. The Stardust recorder does not directly measure
leep time, but rather breathing and airflow. Thus, we
stimated sleep time from time in bed, but did not measure
t directly, potentially introducing error in the calculation of
he AHI. Invasive pacing was not feasible in the outpatient
nvironment, where full sleep studies are performed in our
nstitution. For safety reasons, the study was conducted on
he cardiology floor with ambulatory sleep assessment.
The ideal form of pacing that may reduce the frequency
f apneic episodes is unknown. The current approach was
hosen because it represented typical physiologic pacing that
s used to prevent low heart rates in other conditions, such
s bradycardia-mediated atrial fibrillation (16). A different
eart rate may have influenced results, though no trend was
vident with the current heart rate that clearly increased
octurnal rates.
onclusions. Temporary atrial pacing does not appear to
educe sleep apnea in subjects with obstructive sleep apnea.
ermanent pacing in the OSA patient population does not
of Apnea Severity
I Pacing Difference (95% CI) p Value
6  20.5 3.4 (9.3 to 2.5) 0.23
7  1 12 (8 to 16) 0.001
7  108 19 (87 to 48) 0.55
5  10 2 (9 to 4) 0.38
8  6.0 0.3 (1.4 to 2.1) 0.70
1  11.2 4.7 (0.7 to 8.7) 0.11
4  3.2 2.1 (4.7 to 0.4) 0.09ices
AA
38.
7
41
7
3.
33.
23.ppear to be justified at this time.
A
T
H
d
R
L
e
a
R
1
1
1
1
1
1
1
383JACC Vol. 47, No. 2, 2006 Krahn et al.
January 17, 2006:379–83 Pacing Does Not Prevent Obstructive Sleep Apneacknowledgments
he authors would like to thank Steve Saunders and Kim
eighway for their tireless efforts in patient recruitment and
ata collection.
eprint requests and correspondence: Dr. Andrew D. Krahn,
ondon Health Sciences Center, University Campus, 339 Wind-
rmere Road, London, Ontario N6A 5A5, Canada. E-mail:
krahn@uwo.ca.
EFERENCES
1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-
disordered breathing among middle-aged adults. N Engl J Med
1993;328:1230–5.
2. Bahammam A, Kryger M. Decision making in obstructive sleep-
disordered breathing. Putting it all together. Clin Chest Med 1998;
19:87–97.
3. Lichstein KL, Riedel BW, Lester KW, et al. Occult sleep apnea in a
recruited sample of older adults with insomnia. J Consult Clin Psychol
1999;67:405–10.
4. Skomro RP, Kryger MH. Clinical presentations of obstructive sleep
apnea syndrome. Prog Cardiovasc Dis 1999;41:331–40.
5. Guilleminault C, Connolly S, Winkle R, et al. Cyclical variation of the
heart rate in sleep apnoea syndrome. Mechanisms and usefulness of
24 h electrocardiography as a screening technique. Lancet 1984;1:
126–31.
6. Garrigue S, Bordier P, Jais P, et al. Benefit of atrial pacing in sleep7. Sleep-related breathing disorders in adults: recommendations for
syndrome definition and measurement techniques in clinical research.
The report of an American Academy of Sleep Medicine Task Force.
Sleep 1999;22:667–89.
8. Luthje L, Unterberg-Buchwald C, Dajani D, et al. Atrial overdrive
pacing in patients with sleep apnea with implanted pacemaker. Am J
Respir Crit Care Med 2005;172:118–22.
9. Pepin JL, Defaye P, Garrigue S, et al. Overdrive atrial pacing does not
improve obstructive sleep apnoea syndrome. Eur Respir J 2005;25:
343–7.
0. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep
apnoea treatment in coronary artery disease: a long-term follow-up
study. Eur Heart J 2004;25:728–34.
1. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered
breathing, sleep apnea, and hypertension in a large community-based
study. Sleep Heart Health Study. JAMA 2000;283:1829–36.
2. Mooe T, Franklin KA, Holmstrom K, et al. Sleep-disordered breath-
ing and coronary artery disease: long-term prognosis. Am J Respir Crit
Care Med 2001;164:1910–3.
3. Peppard PE, Young T, Palta M, et al. Prospective study of the
association between sleep-disordered breathing and hypertension.
N Engl J Med 2000;342:1378–84.
4. Gottlieb DJ. Cardiac pacing—a novel therapy for sleep apnea? N Engl
J Med 2002;346:444–5.
5. Guilleminault C, Briskin JG, Greenfield MS, et al. The impact of
autonomic nervous system dysfunction on breathing during sleep.
Sleep 1981;4:263–78.
6. Gillis AM, Connolly SJ, Lacombe P, et al. Randomized crossover
comparison of DDDR versus VDD pacing after atrioventricular
junction ablation for prevention of atrial fibrillation. The atrial pacing
peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investi-apnea syndrome. N Engl J Med 2002;346:404–12. gators. Circulation 2000;102:736–41.
